Mike Romanos appointed as CEO of Crescendo Biologics
5 January 2011 | By Citigate Dewe Rogerson Ltd
Crescendo Biologics Limited (Crescendo) today announces the appointment of Mike Romanos as Chief Executive Officer...
List view / Grid view
News
Quantum Pharmaceutical Appoints New National Account Manager
5 January 2011 | By Smith & Smith PR
Unlicensed medicines manufacturer Quantum Pharmaceutical has appointed Pauline Carter as its new National Account Manager...
Wyatt Technology MALS detectors used in breakthrough virus research
5 January 2011 | By The Scott Partnership
Landmark study transforms the previous scientific understanding of immunity to viral diseases like the common cold, 'winter vomiting' and gastroenteritis...
eC-SSRS solution from ERT facilitates compliance with new FDA guidance
5 January 2011 | By The Scott Partnership
ERT's eC-SSRS solution facilitates compliance with FDA guidance on suicidality assessment in clinical trials...
arGEN-X signs discovery and development alliance with Lilly
5 January 2011 | By Citigate Dewe Rogerson
arGEN-X BV, announced it has entered into an alliance with Lilly to discover and develop novel therapeutic antibody products against targets submitted by Lilly...
GSK Head of Patient Recruitment Joins Exco InTouch
4 January 2011 | By The Scott Partnership
Exco InTouch, announces the appointment of Judith Teall. The newly created position will drive Exco InTouch to build on its “patient centric” approach to managing clinical trials...
NICE recommends Votrient®▼ (pazopanib) for the first-line treatment of advanced renal cell carcinoma (RCC)
4 January 2011 | By GlaxoSmithKline
Targeted oral treatment slows down the progression of advanced kidney cancer...
AstraZeneca and Abbott end license agreement for the development of Certriad
3 January 2011 | By AstraZeneca
AstraZeneca has notified Abbott that it will discontinue the development of CERTRIAD on 22 January 2011...
ERT Announces the Appointment of Joel Morganroth, MD as Interim CEO
21 December 2010 | By The Scott Partnership
ERT, today confirmed that the effective date of the previously announced retirement of Dr. Michael J. McKelvey, its President and CEO, is December 21, 2010...
PharmaNet Offers Guidance on Regulatory Pathway for Biosimilars Development Following Recent FDA Hearing
20 December 2010 | By The Scott Partnership
PharmaNet, are available to offer guidance on the regulatory pathway for biosimilar development...
Proximagen acquires two CNS drug development programmes from GlaxoSmithKline
20 December 2010 | By M:Communications
Proximagen, has signed an exclusive agreement with GSK to acquire the global rights to two drug development programmes...
The Scott Partnership to Present Short Course on Marketing in Asia Pacific at Pittcon 2011
16 December 2010 | By The Scott Partnership
The Scott Partnership, has been selected by the organisers of Pittcon 2011 to deliver a short-course entitled ‘Marketing in Asia Pacific...
ERT Unveils Full Range of ePRO Solutions Providing the Power of Choice for Clinical Trial Sponsors
16 December 2010 | By The Scott Partnership
ERT, today announced the launch of its comprehensive suite of electronic patient-reported outcome (ePRO) solutions...
Sigma® Life Science Creates World’s First Knock-in Rats using Zinc Finger Nuclease Technology
13 December 2010 | By Sigma Life Science
Sigma Life Science, announced that its SAGE Labs initiative has successfully used its proprietary CompoZr® ZFN technology...
Infinite® 200 PRO offers environmental control for cell-based applications
9 December 2010 | By kdm communications limited
Tecan has launched a Gas Control Module (GCM™) for its Infinite 200 PRO multimode microplate reader...
